Loading clinical trials...
Loading clinical trials...
the Effect of AQP-1 Polymorphism on Fluid Status of Hemodialysis Patients
It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current center will be enrolled to the study after informed consent. Blood samples will be collected for gene-typing. Fluid status including blood pressure, weekly UF and intra-dialysis body weight change will be collected through their clinical records.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Renji Hospital
Shanghai, Shanghai Municipality, China
Start Date
December 1, 2022
Primary Completion Date
January 30, 2023
Completion Date
February 28, 2023
Last Updated
November 1, 2022
250
ESTIMATED participants
observational study, no intervention
OTHER
Lead Sponsor
RenJi Hospital
NCT05654103
NCT06842927
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05735743